Roche Raises Outlook Despite US Biosimilars, Sees Spark Buy By Year-End

 
• By Sten Stovall
  
Growth
Roche looking beyond cancer drugs as newer medicines spur growth • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip